Global Oral Solid Dosage CDMO Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Oral Solid Dosage CDMO market size will reach USD 2679 million in 2031, growing at a CAGR of 6.2% over the analysis period.
Oral solid dosage CDMO (Contract Development and Manufacturing Organization) is a professional outsourcing model that provides pharmaceutical companies with a full chain of services from drug research and development, process development, pilot scale-up, clinical sample production to commercial production. Its core lies in helping customers shorten the R&D cycle, reduce production costs, and achieve rapid transformation of products from laboratory to market through the integration of technology platforms and production capabilities.
This report is a detailed and comprehensive analysis for global Oral Solid Dosage CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Solid Dosage CDMO market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage CDMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage CDMO market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Solid Dosage CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Solid Dosage CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adragos Pharma, Aenova, Agno Pharma, Alcami, Almac, Cambrex, Rubicon Research, Catalent Pharma Solutions, Hetero, Ind-Swift Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oral Solid Dosage CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Solid Dosage CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Solid Dosage CDMO, with revenue, gross margin, and global market share of Oral Solid Dosage CDMO from 2020 to 2025.
Chapter 3, the Oral Solid Dosage CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oral Solid Dosage CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Solid Dosage CDMO.
Chapter 13, to describe Oral Solid Dosage CDMO research findings and conclusion.
Oral solid dosage CDMO (Contract Development and Manufacturing Organization) is a professional outsourcing model that provides pharmaceutical companies with a full chain of services from drug research and development, process development, pilot scale-up, clinical sample production to commercial production. Its core lies in helping customers shorten the R&D cycle, reduce production costs, and achieve rapid transformation of products from laboratory to market through the integration of technology platforms and production capabilities.
This report is a detailed and comprehensive analysis for global Oral Solid Dosage CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Oral Solid Dosage CDMO market size and forecasts, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage CDMO market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Oral Solid Dosage CDMO market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Solid Dosage CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Solid Dosage CDMO market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adragos Pharma, Aenova, Agno Pharma, Alcami, Almac, Cambrex, Rubicon Research, Catalent Pharma Solutions, Hetero, Ind-Swift Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Oral Solid Dosage CDMO market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Chemical Drug CDMO
- Biological Drug CDMO
- Ordinary Oral Solid Preparations
- High-Activity and Special Preparations
- Adragos Pharma
- Aenova
- Agno Pharma
- Alcami
- Almac
- Cambrex
- Rubicon Research
- Catalent Pharma Solutions
- Hetero
- Ind-Swift Laboratories
- Lonza
- PharmaSource
- Recipharm
- Rottendorf Pharma
- Abbott
- Skyepharma
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Oral Solid Dosage CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Oral Solid Dosage CDMO, with revenue, gross margin, and global market share of Oral Solid Dosage CDMO from 2020 to 2025.
Chapter 3, the Oral Solid Dosage CDMO competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Oral Solid Dosage CDMO market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Oral Solid Dosage CDMO.
Chapter 13, to describe Oral Solid Dosage CDMO research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oral Solid Dosage CDMO by Type
1.3.1 Overview: Global Oral Solid Dosage CDMO Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oral Solid Dosage CDMO Consumption Value Market Share by Type in 2024
1.3.3 Chemical Drug CDMO
1.3.4 Biological Drug CDMO
1.4 Global Oral Solid Dosage CDMO Market by Application
1.4.1 Overview: Global Oral Solid Dosage CDMO Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Ordinary Oral Solid Preparations
1.4.3 High-Activity and Special Preparations
1.5 Global Oral Solid Dosage CDMO Market Size & Forecast
1.6 Global Oral Solid Dosage CDMO Market Size and Forecast by Region
1.6.1 Global Oral Solid Dosage CDMO Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oral Solid Dosage CDMO Market Size by Region, (2020-2031)
1.6.3 North America Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.4 Europe Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.6 South America Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Adragos Pharma
2.1.1 Adragos Pharma Details
2.1.2 Adragos Pharma Major Business
2.1.3 Adragos Pharma Oral Solid Dosage CDMO Product and Solutions
2.1.4 Adragos Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Adragos Pharma Recent Developments and Future Plans
2.2 Aenova
2.2.1 Aenova Details
2.2.2 Aenova Major Business
2.2.3 Aenova Oral Solid Dosage CDMO Product and Solutions
2.2.4 Aenova Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Aenova Recent Developments and Future Plans
2.3 Agno Pharma
2.3.1 Agno Pharma Details
2.3.2 Agno Pharma Major Business
2.3.3 Agno Pharma Oral Solid Dosage CDMO Product and Solutions
2.3.4 Agno Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Agno Pharma Recent Developments and Future Plans
2.4 Alcami
2.4.1 Alcami Details
2.4.2 Alcami Major Business
2.4.3 Alcami Oral Solid Dosage CDMO Product and Solutions
2.4.4 Alcami Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Alcami Recent Developments and Future Plans
2.5 Almac
2.5.1 Almac Details
2.5.2 Almac Major Business
2.5.3 Almac Oral Solid Dosage CDMO Product and Solutions
2.5.4 Almac Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Almac Recent Developments and Future Plans
2.6 Cambrex
2.6.1 Cambrex Details
2.6.2 Cambrex Major Business
2.6.3 Cambrex Oral Solid Dosage CDMO Product and Solutions
2.6.4 Cambrex Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Cambrex Recent Developments and Future Plans
2.7 Rubicon Research
2.7.1 Rubicon Research Details
2.7.2 Rubicon Research Major Business
2.7.3 Rubicon Research Oral Solid Dosage CDMO Product and Solutions
2.7.4 Rubicon Research Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Rubicon Research Recent Developments and Future Plans
2.8 Catalent Pharma Solutions
2.8.1 Catalent Pharma Solutions Details
2.8.2 Catalent Pharma Solutions Major Business
2.8.3 Catalent Pharma Solutions Oral Solid Dosage CDMO Product and Solutions
2.8.4 Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Catalent Pharma Solutions Recent Developments and Future Plans
2.9 Hetero
2.9.1 Hetero Details
2.9.2 Hetero Major Business
2.9.3 Hetero Oral Solid Dosage CDMO Product and Solutions
2.9.4 Hetero Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Hetero Recent Developments and Future Plans
2.10 Ind-Swift Laboratories
2.10.1 Ind-Swift Laboratories Details
2.10.2 Ind-Swift Laboratories Major Business
2.10.3 Ind-Swift Laboratories Oral Solid Dosage CDMO Product and Solutions
2.10.4 Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Ind-Swift Laboratories Recent Developments and Future Plans
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business
2.11.3 Lonza Oral Solid Dosage CDMO Product and Solutions
2.11.4 Lonza Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Lonza Recent Developments and Future Plans
2.12 PharmaSource
2.12.1 PharmaSource Details
2.12.2 PharmaSource Major Business
2.12.3 PharmaSource Oral Solid Dosage CDMO Product and Solutions
2.12.4 PharmaSource Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 PharmaSource Recent Developments and Future Plans
2.13 Recipharm
2.13.1 Recipharm Details
2.13.2 Recipharm Major Business
2.13.3 Recipharm Oral Solid Dosage CDMO Product and Solutions
2.13.4 Recipharm Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Recipharm Recent Developments and Future Plans
2.14 Rottendorf Pharma
2.14.1 Rottendorf Pharma Details
2.14.2 Rottendorf Pharma Major Business
2.14.3 Rottendorf Pharma Oral Solid Dosage CDMO Product and Solutions
2.14.4 Rottendorf Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Rottendorf Pharma Recent Developments and Future Plans
2.15 Abbott
2.15.1 Abbott Details
2.15.2 Abbott Major Business
2.15.3 Abbott Oral Solid Dosage CDMO Product and Solutions
2.15.4 Abbott Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Abbott Recent Developments and Future Plans
2.16 Skyepharma
2.16.1 Skyepharma Details
2.16.2 Skyepharma Major Business
2.16.3 Skyepharma Oral Solid Dosage CDMO Product and Solutions
2.16.4 Skyepharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Skyepharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oral Solid Dosage CDMO Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Oral Solid Dosage CDMO by Company Revenue
3.2.2 Top 3 Oral Solid Dosage CDMO Players Market Share in 2024
3.2.3 Top 6 Oral Solid Dosage CDMO Players Market Share in 2024
3.3 Oral Solid Dosage CDMO Market: Overall Company Footprint Analysis
3.3.1 Oral Solid Dosage CDMO Market: Region Footprint
3.3.2 Oral Solid Dosage CDMO Market: Company Product Type Footprint
3.3.3 Oral Solid Dosage CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oral Solid Dosage CDMO Consumption Value and Market Share by Type (2020-2025)
4.2 Global Oral Solid Dosage CDMO Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2025)
5.2 Global Oral Solid Dosage CDMO Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
6.2 North America Oral Solid Dosage CDMO Market Size by Application (2020-2031)
6.3 North America Oral Solid Dosage CDMO Market Size by Country
6.3.1 North America Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
6.3.2 United States Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
6.3.3 Canada Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
6.3.4 Mexico Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
7.2 Europe Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
7.3 Europe Oral Solid Dosage CDMO Market Size by Country
7.3.1 Europe Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
7.3.2 Germany Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.3 France Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.5 Russia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.6 Italy Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Oral Solid Dosage CDMO Market Size by Region
8.3.1 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Region (2020-2031)
8.3.2 China Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.3 Japan Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.4 South Korea Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.5 India Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.7 Australia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
9.2 South America Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
9.3 South America Oral Solid Dosage CDMO Market Size by Country
9.3.1 South America Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
9.3.2 Brazil Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
9.3.3 Argentina Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Oral Solid Dosage CDMO Market Size by Country
10.3.1 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
10.3.2 Turkey Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
10.3.4 UAE Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Oral Solid Dosage CDMO Market Drivers
11.2 Oral Solid Dosage CDMO Market Restraints
11.3 Oral Solid Dosage CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oral Solid Dosage CDMO Industry Chain
12.2 Oral Solid Dosage CDMO Upstream Analysis
12.3 Oral Solid Dosage CDMO Midstream Analysis
12.4 Oral Solid Dosage CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Oral Solid Dosage CDMO by Type
1.3.1 Overview: Global Oral Solid Dosage CDMO Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Oral Solid Dosage CDMO Consumption Value Market Share by Type in 2024
1.3.3 Chemical Drug CDMO
1.3.4 Biological Drug CDMO
1.4 Global Oral Solid Dosage CDMO Market by Application
1.4.1 Overview: Global Oral Solid Dosage CDMO Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Ordinary Oral Solid Preparations
1.4.3 High-Activity and Special Preparations
1.5 Global Oral Solid Dosage CDMO Market Size & Forecast
1.6 Global Oral Solid Dosage CDMO Market Size and Forecast by Region
1.6.1 Global Oral Solid Dosage CDMO Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Oral Solid Dosage CDMO Market Size by Region, (2020-2031)
1.6.3 North America Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.4 Europe Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.6 South America Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Oral Solid Dosage CDMO Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Adragos Pharma
2.1.1 Adragos Pharma Details
2.1.2 Adragos Pharma Major Business
2.1.3 Adragos Pharma Oral Solid Dosage CDMO Product and Solutions
2.1.4 Adragos Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Adragos Pharma Recent Developments and Future Plans
2.2 Aenova
2.2.1 Aenova Details
2.2.2 Aenova Major Business
2.2.3 Aenova Oral Solid Dosage CDMO Product and Solutions
2.2.4 Aenova Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Aenova Recent Developments and Future Plans
2.3 Agno Pharma
2.3.1 Agno Pharma Details
2.3.2 Agno Pharma Major Business
2.3.3 Agno Pharma Oral Solid Dosage CDMO Product and Solutions
2.3.4 Agno Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Agno Pharma Recent Developments and Future Plans
2.4 Alcami
2.4.1 Alcami Details
2.4.2 Alcami Major Business
2.4.3 Alcami Oral Solid Dosage CDMO Product and Solutions
2.4.4 Alcami Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Alcami Recent Developments and Future Plans
2.5 Almac
2.5.1 Almac Details
2.5.2 Almac Major Business
2.5.3 Almac Oral Solid Dosage CDMO Product and Solutions
2.5.4 Almac Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Almac Recent Developments and Future Plans
2.6 Cambrex
2.6.1 Cambrex Details
2.6.2 Cambrex Major Business
2.6.3 Cambrex Oral Solid Dosage CDMO Product and Solutions
2.6.4 Cambrex Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Cambrex Recent Developments and Future Plans
2.7 Rubicon Research
2.7.1 Rubicon Research Details
2.7.2 Rubicon Research Major Business
2.7.3 Rubicon Research Oral Solid Dosage CDMO Product and Solutions
2.7.4 Rubicon Research Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Rubicon Research Recent Developments and Future Plans
2.8 Catalent Pharma Solutions
2.8.1 Catalent Pharma Solutions Details
2.8.2 Catalent Pharma Solutions Major Business
2.8.3 Catalent Pharma Solutions Oral Solid Dosage CDMO Product and Solutions
2.8.4 Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Catalent Pharma Solutions Recent Developments and Future Plans
2.9 Hetero
2.9.1 Hetero Details
2.9.2 Hetero Major Business
2.9.3 Hetero Oral Solid Dosage CDMO Product and Solutions
2.9.4 Hetero Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Hetero Recent Developments and Future Plans
2.10 Ind-Swift Laboratories
2.10.1 Ind-Swift Laboratories Details
2.10.2 Ind-Swift Laboratories Major Business
2.10.3 Ind-Swift Laboratories Oral Solid Dosage CDMO Product and Solutions
2.10.4 Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Ind-Swift Laboratories Recent Developments and Future Plans
2.11 Lonza
2.11.1 Lonza Details
2.11.2 Lonza Major Business
2.11.3 Lonza Oral Solid Dosage CDMO Product and Solutions
2.11.4 Lonza Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Lonza Recent Developments and Future Plans
2.12 PharmaSource
2.12.1 PharmaSource Details
2.12.2 PharmaSource Major Business
2.12.3 PharmaSource Oral Solid Dosage CDMO Product and Solutions
2.12.4 PharmaSource Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 PharmaSource Recent Developments and Future Plans
2.13 Recipharm
2.13.1 Recipharm Details
2.13.2 Recipharm Major Business
2.13.3 Recipharm Oral Solid Dosage CDMO Product and Solutions
2.13.4 Recipharm Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Recipharm Recent Developments and Future Plans
2.14 Rottendorf Pharma
2.14.1 Rottendorf Pharma Details
2.14.2 Rottendorf Pharma Major Business
2.14.3 Rottendorf Pharma Oral Solid Dosage CDMO Product and Solutions
2.14.4 Rottendorf Pharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Rottendorf Pharma Recent Developments and Future Plans
2.15 Abbott
2.15.1 Abbott Details
2.15.2 Abbott Major Business
2.15.3 Abbott Oral Solid Dosage CDMO Product and Solutions
2.15.4 Abbott Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Abbott Recent Developments and Future Plans
2.16 Skyepharma
2.16.1 Skyepharma Details
2.16.2 Skyepharma Major Business
2.16.3 Skyepharma Oral Solid Dosage CDMO Product and Solutions
2.16.4 Skyepharma Oral Solid Dosage CDMO Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Skyepharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Oral Solid Dosage CDMO Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Oral Solid Dosage CDMO by Company Revenue
3.2.2 Top 3 Oral Solid Dosage CDMO Players Market Share in 2024
3.2.3 Top 6 Oral Solid Dosage CDMO Players Market Share in 2024
3.3 Oral Solid Dosage CDMO Market: Overall Company Footprint Analysis
3.3.1 Oral Solid Dosage CDMO Market: Region Footprint
3.3.2 Oral Solid Dosage CDMO Market: Company Product Type Footprint
3.3.3 Oral Solid Dosage CDMO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Oral Solid Dosage CDMO Consumption Value and Market Share by Type (2020-2025)
4.2 Global Oral Solid Dosage CDMO Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2025)
5.2 Global Oral Solid Dosage CDMO Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
6.2 North America Oral Solid Dosage CDMO Market Size by Application (2020-2031)
6.3 North America Oral Solid Dosage CDMO Market Size by Country
6.3.1 North America Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
6.3.2 United States Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
6.3.3 Canada Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
6.3.4 Mexico Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
7.2 Europe Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
7.3 Europe Oral Solid Dosage CDMO Market Size by Country
7.3.1 Europe Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
7.3.2 Germany Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.3 France Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.5 Russia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
7.3.6 Italy Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Oral Solid Dosage CDMO Market Size by Region
8.3.1 Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Region (2020-2031)
8.3.2 China Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.3 Japan Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.4 South Korea Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.5 India Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
8.3.7 Australia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
9.2 South America Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
9.3 South America Oral Solid Dosage CDMO Market Size by Country
9.3.1 South America Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
9.3.2 Brazil Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
9.3.3 Argentina Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Oral Solid Dosage CDMO Market Size by Country
10.3.1 Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Country (2020-2031)
10.3.2 Turkey Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
10.3.4 UAE Oral Solid Dosage CDMO Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Oral Solid Dosage CDMO Market Drivers
11.2 Oral Solid Dosage CDMO Market Restraints
11.3 Oral Solid Dosage CDMO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Oral Solid Dosage CDMO Industry Chain
12.2 Oral Solid Dosage CDMO Upstream Analysis
12.3 Oral Solid Dosage CDMO Midstream Analysis
12.4 Oral Solid Dosage CDMO Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Oral Solid Dosage CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oral Solid Dosage CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Oral Solid Dosage CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Oral Solid Dosage CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Adragos Pharma Company Information, Head Office, and Major Competitors
Table 6. Adragos Pharma Major Business
Table 7. Adragos Pharma Oral Solid Dosage CDMO Product and Solutions
Table 8. Adragos Pharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Adragos Pharma Recent Developments and Future Plans
Table 10. Aenova Company Information, Head Office, and Major Competitors
Table 11. Aenova Major Business
Table 12. Aenova Oral Solid Dosage CDMO Product and Solutions
Table 13. Aenova Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Aenova Recent Developments and Future Plans
Table 15. Agno Pharma Company Information, Head Office, and Major Competitors
Table 16. Agno Pharma Major Business
Table 17. Agno Pharma Oral Solid Dosage CDMO Product and Solutions
Table 18. Agno Pharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Alcami Company Information, Head Office, and Major Competitors
Table 20. Alcami Major Business
Table 21. Alcami Oral Solid Dosage CDMO Product and Solutions
Table 22. Alcami Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Alcami Recent Developments and Future Plans
Table 24. Almac Company Information, Head Office, and Major Competitors
Table 25. Almac Major Business
Table 26. Almac Oral Solid Dosage CDMO Product and Solutions
Table 27. Almac Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Almac Recent Developments and Future Plans
Table 29. Cambrex Company Information, Head Office, and Major Competitors
Table 30. Cambrex Major Business
Table 31. Cambrex Oral Solid Dosage CDMO Product and Solutions
Table 32. Cambrex Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Cambrex Recent Developments and Future Plans
Table 34. Rubicon Research Company Information, Head Office, and Major Competitors
Table 35. Rubicon Research Major Business
Table 36. Rubicon Research Oral Solid Dosage CDMO Product and Solutions
Table 37. Rubicon Research Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Rubicon Research Recent Developments and Future Plans
Table 39. Catalent Pharma Solutions Company Information, Head Office, and Major Competitors
Table 40. Catalent Pharma Solutions Major Business
Table 41. Catalent Pharma Solutions Oral Solid Dosage CDMO Product and Solutions
Table 42. Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Catalent Pharma Solutions Recent Developments and Future Plans
Table 44. Hetero Company Information, Head Office, and Major Competitors
Table 45. Hetero Major Business
Table 46. Hetero Oral Solid Dosage CDMO Product and Solutions
Table 47. Hetero Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Hetero Recent Developments and Future Plans
Table 49. Ind-Swift Laboratories Company Information, Head Office, and Major Competitors
Table 50. Ind-Swift Laboratories Major Business
Table 51. Ind-Swift Laboratories Oral Solid Dosage CDMO Product and Solutions
Table 52. Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Ind-Swift Laboratories Recent Developments and Future Plans
Table 54. Lonza Company Information, Head Office, and Major Competitors
Table 55. Lonza Major Business
Table 56. Lonza Oral Solid Dosage CDMO Product and Solutions
Table 57. Lonza Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Lonza Recent Developments and Future Plans
Table 59. PharmaSource Company Information, Head Office, and Major Competitors
Table 60. PharmaSource Major Business
Table 61. PharmaSource Oral Solid Dosage CDMO Product and Solutions
Table 62. PharmaSource Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. PharmaSource Recent Developments and Future Plans
Table 64. Recipharm Company Information, Head Office, and Major Competitors
Table 65. Recipharm Major Business
Table 66. Recipharm Oral Solid Dosage CDMO Product and Solutions
Table 67. Recipharm Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Recipharm Recent Developments and Future Plans
Table 69. Rottendorf Pharma Company Information, Head Office, and Major Competitors
Table 70. Rottendorf Pharma Major Business
Table 71. Rottendorf Pharma Oral Solid Dosage CDMO Product and Solutions
Table 72. Rottendorf Pharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Rottendorf Pharma Recent Developments and Future Plans
Table 74. Abbott Company Information, Head Office, and Major Competitors
Table 75. Abbott Major Business
Table 76. Abbott Oral Solid Dosage CDMO Product and Solutions
Table 77. Abbott Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Abbott Recent Developments and Future Plans
Table 79. Skyepharma Company Information, Head Office, and Major Competitors
Table 80. Skyepharma Major Business
Table 81. Skyepharma Oral Solid Dosage CDMO Product and Solutions
Table 82. Skyepharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Skyepharma Recent Developments and Future Plans
Table 84. Global Oral Solid Dosage CDMO Revenue (USD Million) by Players (2020-2025)
Table 85. Global Oral Solid Dosage CDMO Revenue Share by Players (2020-2025)
Table 86. Breakdown of Oral Solid Dosage CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 87. Market Position of Players in Oral Solid Dosage CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 88. Head Office of Key Oral Solid Dosage CDMO Players
Table 89. Oral Solid Dosage CDMO Market: Company Product Type Footprint
Table 90. Oral Solid Dosage CDMO Market: Company Product Application Footprint
Table 91. Oral Solid Dosage CDMO New Market Entrants and Barriers to Market Entry
Table 92. Oral Solid Dosage CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 93. Global Oral Solid Dosage CDMO Consumption Value (USD Million) by Type (2020-2025)
Table 94. Global Oral Solid Dosage CDMO Consumption Value Share by Type (2020-2025)
Table 95. Global Oral Solid Dosage CDMO Consumption Value Forecast by Type (2026-2031)
Table 96. Global Oral Solid Dosage CDMO Consumption Value by Application (2020-2025)
Table 97. Global Oral Solid Dosage CDMO Consumption Value Forecast by Application (2026-2031)
Table 98. North America Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 99. North America Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 100. North America Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 101. North America Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 102. North America Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 105. Europe Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 106. Europe Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 107. Europe Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 108. Europe Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 109. Europe Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 110. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 111. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 112. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 113. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 114. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 115. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 116. South America Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 117. South America Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 118. South America Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 119. South America Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 120. South America Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 121. South America Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 123. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 124. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 125. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 126. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 127. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Global Key Players of Oral Solid Dosage CDMO Upstream (Raw Materials)
Table 129. Global Oral Solid Dosage CDMO Typical Customers
Table 1. Global Oral Solid Dosage CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Oral Solid Dosage CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Oral Solid Dosage CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Oral Solid Dosage CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Adragos Pharma Company Information, Head Office, and Major Competitors
Table 6. Adragos Pharma Major Business
Table 7. Adragos Pharma Oral Solid Dosage CDMO Product and Solutions
Table 8. Adragos Pharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Adragos Pharma Recent Developments and Future Plans
Table 10. Aenova Company Information, Head Office, and Major Competitors
Table 11. Aenova Major Business
Table 12. Aenova Oral Solid Dosage CDMO Product and Solutions
Table 13. Aenova Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Aenova Recent Developments and Future Plans
Table 15. Agno Pharma Company Information, Head Office, and Major Competitors
Table 16. Agno Pharma Major Business
Table 17. Agno Pharma Oral Solid Dosage CDMO Product and Solutions
Table 18. Agno Pharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Alcami Company Information, Head Office, and Major Competitors
Table 20. Alcami Major Business
Table 21. Alcami Oral Solid Dosage CDMO Product and Solutions
Table 22. Alcami Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Alcami Recent Developments and Future Plans
Table 24. Almac Company Information, Head Office, and Major Competitors
Table 25. Almac Major Business
Table 26. Almac Oral Solid Dosage CDMO Product and Solutions
Table 27. Almac Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Almac Recent Developments and Future Plans
Table 29. Cambrex Company Information, Head Office, and Major Competitors
Table 30. Cambrex Major Business
Table 31. Cambrex Oral Solid Dosage CDMO Product and Solutions
Table 32. Cambrex Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Cambrex Recent Developments and Future Plans
Table 34. Rubicon Research Company Information, Head Office, and Major Competitors
Table 35. Rubicon Research Major Business
Table 36. Rubicon Research Oral Solid Dosage CDMO Product and Solutions
Table 37. Rubicon Research Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Rubicon Research Recent Developments and Future Plans
Table 39. Catalent Pharma Solutions Company Information, Head Office, and Major Competitors
Table 40. Catalent Pharma Solutions Major Business
Table 41. Catalent Pharma Solutions Oral Solid Dosage CDMO Product and Solutions
Table 42. Catalent Pharma Solutions Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Catalent Pharma Solutions Recent Developments and Future Plans
Table 44. Hetero Company Information, Head Office, and Major Competitors
Table 45. Hetero Major Business
Table 46. Hetero Oral Solid Dosage CDMO Product and Solutions
Table 47. Hetero Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Hetero Recent Developments and Future Plans
Table 49. Ind-Swift Laboratories Company Information, Head Office, and Major Competitors
Table 50. Ind-Swift Laboratories Major Business
Table 51. Ind-Swift Laboratories Oral Solid Dosage CDMO Product and Solutions
Table 52. Ind-Swift Laboratories Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Ind-Swift Laboratories Recent Developments and Future Plans
Table 54. Lonza Company Information, Head Office, and Major Competitors
Table 55. Lonza Major Business
Table 56. Lonza Oral Solid Dosage CDMO Product and Solutions
Table 57. Lonza Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Lonza Recent Developments and Future Plans
Table 59. PharmaSource Company Information, Head Office, and Major Competitors
Table 60. PharmaSource Major Business
Table 61. PharmaSource Oral Solid Dosage CDMO Product and Solutions
Table 62. PharmaSource Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. PharmaSource Recent Developments and Future Plans
Table 64. Recipharm Company Information, Head Office, and Major Competitors
Table 65. Recipharm Major Business
Table 66. Recipharm Oral Solid Dosage CDMO Product and Solutions
Table 67. Recipharm Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Recipharm Recent Developments and Future Plans
Table 69. Rottendorf Pharma Company Information, Head Office, and Major Competitors
Table 70. Rottendorf Pharma Major Business
Table 71. Rottendorf Pharma Oral Solid Dosage CDMO Product and Solutions
Table 72. Rottendorf Pharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Rottendorf Pharma Recent Developments and Future Plans
Table 74. Abbott Company Information, Head Office, and Major Competitors
Table 75. Abbott Major Business
Table 76. Abbott Oral Solid Dosage CDMO Product and Solutions
Table 77. Abbott Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. Abbott Recent Developments and Future Plans
Table 79. Skyepharma Company Information, Head Office, and Major Competitors
Table 80. Skyepharma Major Business
Table 81. Skyepharma Oral Solid Dosage CDMO Product and Solutions
Table 82. Skyepharma Oral Solid Dosage CDMO Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Skyepharma Recent Developments and Future Plans
Table 84. Global Oral Solid Dosage CDMO Revenue (USD Million) by Players (2020-2025)
Table 85. Global Oral Solid Dosage CDMO Revenue Share by Players (2020-2025)
Table 86. Breakdown of Oral Solid Dosage CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 87. Market Position of Players in Oral Solid Dosage CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 88. Head Office of Key Oral Solid Dosage CDMO Players
Table 89. Oral Solid Dosage CDMO Market: Company Product Type Footprint
Table 90. Oral Solid Dosage CDMO Market: Company Product Application Footprint
Table 91. Oral Solid Dosage CDMO New Market Entrants and Barriers to Market Entry
Table 92. Oral Solid Dosage CDMO Mergers, Acquisition, Agreements, and Collaborations
Table 93. Global Oral Solid Dosage CDMO Consumption Value (USD Million) by Type (2020-2025)
Table 94. Global Oral Solid Dosage CDMO Consumption Value Share by Type (2020-2025)
Table 95. Global Oral Solid Dosage CDMO Consumption Value Forecast by Type (2026-2031)
Table 96. Global Oral Solid Dosage CDMO Consumption Value by Application (2020-2025)
Table 97. Global Oral Solid Dosage CDMO Consumption Value Forecast by Application (2026-2031)
Table 98. North America Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 99. North America Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 100. North America Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 101. North America Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 102. North America Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 105. Europe Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 106. Europe Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 107. Europe Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 108. Europe Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 109. Europe Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 110. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 111. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 112. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 113. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 114. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Region (2020-2025) & (USD Million)
Table 115. Asia-Pacific Oral Solid Dosage CDMO Consumption Value by Region (2026-2031) & (USD Million)
Table 116. South America Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 117. South America Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 118. South America Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 119. South America Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 120. South America Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 121. South America Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 122. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Type (2020-2025) & (USD Million)
Table 123. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Type (2026-2031) & (USD Million)
Table 124. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Application (2020-2025) & (USD Million)
Table 125. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Application (2026-2031) & (USD Million)
Table 126. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Country (2020-2025) & (USD Million)
Table 127. Middle East & Africa Oral Solid Dosage CDMO Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Global Key Players of Oral Solid Dosage CDMO Upstream (Raw Materials)
Table 129. Global Oral Solid Dosage CDMO Typical Customers
LIST OF FIGURES
Figure 1. Oral Solid Dosage CDMO Picture
Figure 2. Global Oral Solid Dosage CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oral Solid Dosage CDMO Consumption Value Market Share by Type in 2024
Figure 4. Chemical Drug CDMO
Figure 5. Biological Drug CDMO
Figure 6. Global Oral Solid Dosage CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Oral Solid Dosage CDMO Consumption Value Market Share by Application in 2024
Figure 8. Ordinary Oral Solid Preparations Picture
Figure 9. High-Activity and Special Preparations Picture
Figure 10. Global Oral Solid Dosage CDMO Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Oral Solid Dosage CDMO Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Market Oral Solid Dosage CDMO Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 13. Global Oral Solid Dosage CDMO Consumption Value Market Share by Region (2020-2031)
Figure 14. Global Oral Solid Dosage CDMO Consumption Value Market Share by Region in 2024
Figure 15. North America Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 16. Europe Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 17. Asia-Pacific Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 18. South America Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 19. Middle East & Africa Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global Oral Solid Dosage CDMO Revenue Share by Players in 2024
Figure 22. Oral Solid Dosage CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 23. Market Share of Oral Solid Dosage CDMO by Player Revenue in 2024
Figure 24. Top 3 Oral Solid Dosage CDMO Players Market Share in 2024
Figure 25. Top 6 Oral Solid Dosage CDMO Players Market Share in 2024
Figure 26. Global Oral Solid Dosage CDMO Consumption Value Share by Type (2020-2025)
Figure 27. Global Oral Solid Dosage CDMO Market Share Forecast by Type (2026-2031)
Figure 28. Global Oral Solid Dosage CDMO Consumption Value Share by Application (2020-2025)
Figure 29. Global Oral Solid Dosage CDMO Market Share Forecast by Application (2026-2031)
Figure 30. North America Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 31. North America Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 32. North America Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 33. United States Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 34. Canada Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 35. Mexico Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 36. Europe Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 37. Europe Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 38. Europe Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 39. Germany Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 40. France Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 41. United Kingdom Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 42. Russia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 43. Italy Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 44. Asia-Pacific Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 45. Asia-Pacific Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 46. Asia-Pacific Oral Solid Dosage CDMO Consumption Value Market Share by Region (2020-2031)
Figure 47. China Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 48. Japan Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 49. South Korea Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 50. India Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 51. Southeast Asia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 52. Australia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 53. South America Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 54. South America Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 55. South America Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 56. Brazil Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 57. Argentina Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 58. Middle East & Africa Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 59. Middle East & Africa Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 60. Middle East & Africa Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 61. Turkey Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 62. Saudi Arabia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 63. UAE Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 64. Oral Solid Dosage CDMO Market Drivers
Figure 65. Oral Solid Dosage CDMO Market Restraints
Figure 66. Oral Solid Dosage CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Oral Solid Dosage CDMO Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. Oral Solid Dosage CDMO Picture
Figure 2. Global Oral Solid Dosage CDMO Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Oral Solid Dosage CDMO Consumption Value Market Share by Type in 2024
Figure 4. Chemical Drug CDMO
Figure 5. Biological Drug CDMO
Figure 6. Global Oral Solid Dosage CDMO Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Oral Solid Dosage CDMO Consumption Value Market Share by Application in 2024
Figure 8. Ordinary Oral Solid Preparations Picture
Figure 9. High-Activity and Special Preparations Picture
Figure 10. Global Oral Solid Dosage CDMO Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 11. Global Oral Solid Dosage CDMO Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 12. Global Market Oral Solid Dosage CDMO Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 13. Global Oral Solid Dosage CDMO Consumption Value Market Share by Region (2020-2031)
Figure 14. Global Oral Solid Dosage CDMO Consumption Value Market Share by Region in 2024
Figure 15. North America Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 16. Europe Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 17. Asia-Pacific Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 18. South America Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 19. Middle East & Africa Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 20. Company Three Recent Developments and Future Plans
Figure 21. Global Oral Solid Dosage CDMO Revenue Share by Players in 2024
Figure 22. Oral Solid Dosage CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 23. Market Share of Oral Solid Dosage CDMO by Player Revenue in 2024
Figure 24. Top 3 Oral Solid Dosage CDMO Players Market Share in 2024
Figure 25. Top 6 Oral Solid Dosage CDMO Players Market Share in 2024
Figure 26. Global Oral Solid Dosage CDMO Consumption Value Share by Type (2020-2025)
Figure 27. Global Oral Solid Dosage CDMO Market Share Forecast by Type (2026-2031)
Figure 28. Global Oral Solid Dosage CDMO Consumption Value Share by Application (2020-2025)
Figure 29. Global Oral Solid Dosage CDMO Market Share Forecast by Application (2026-2031)
Figure 30. North America Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 31. North America Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 32. North America Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 33. United States Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 34. Canada Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 35. Mexico Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 36. Europe Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 37. Europe Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 38. Europe Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 39. Germany Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 40. France Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 41. United Kingdom Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 42. Russia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 43. Italy Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 44. Asia-Pacific Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 45. Asia-Pacific Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 46. Asia-Pacific Oral Solid Dosage CDMO Consumption Value Market Share by Region (2020-2031)
Figure 47. China Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 48. Japan Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 49. South Korea Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 50. India Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 51. Southeast Asia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 52. Australia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 53. South America Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 54. South America Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 55. South America Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 56. Brazil Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 57. Argentina Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 58. Middle East & Africa Oral Solid Dosage CDMO Consumption Value Market Share by Type (2020-2031)
Figure 59. Middle East & Africa Oral Solid Dosage CDMO Consumption Value Market Share by Application (2020-2031)
Figure 60. Middle East & Africa Oral Solid Dosage CDMO Consumption Value Market Share by Country (2020-2031)
Figure 61. Turkey Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 62. Saudi Arabia Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 63. UAE Oral Solid Dosage CDMO Consumption Value (2020-2031) & (USD Million)
Figure 64. Oral Solid Dosage CDMO Market Drivers
Figure 65. Oral Solid Dosage CDMO Market Restraints
Figure 66. Oral Solid Dosage CDMO Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Oral Solid Dosage CDMO Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
